Turnover: 43.7 billion USD (2022)

Country: United States

Group of over 100,000 people

Abbott is an American pharmaceutical group based in Chicago and founded by Wallace Calvin Abbott. The group is present in 163 countries.

A pioneer and leader in the pharmaceutical industry, Abbott created the first HIV test in 1985. The group spends several billion on research and development every year.

It operates in the cardiovascular, diabetes, medical diagnostics, neuromulation and nutrition markets.

Its subsidiary Abbott Nutrition is one of the leading producers of infant milk in the USA

News

Abbott: improvement and investment 20/06/2023

  • Abbott generates around 60% of its sales outside the United States
  • The company achieved sales of $43.6 billion in 2022
  • The company acquired St. Jude Medical in 2017 for $25 billion

Abbott Nutrition relaunches baby milk powder production 04/06/2022

  • Abbott Nutrition is one of four companies that account for approximately 90% of baby milk powder production in the United States, including Reckitt and Gerber

Abbott acquires St. Jude for $25 billion 28/04/2018

  • Abbott Laboratories bought St. Jude Medical for $25 billion (€22.03 billion).
  • Abbott must also finance the planned acquisition of Alere, announced in February for $5.8 billion.
  • Abbott plans to refinance St. Jude's net debt of around $5.7 billion.
  • Following the acquisition, Abbott's cardiovascular devices business will have sales of $8.7 billion, placing the group in a leading position in this market.

Financial Data

DUNS: 602950206

Legal Name: ABBOTT FRANCE

Address: 3 PL GUSTAVE EIFFEL BATIMENT FLORENCE, 94150 RUNGIS

Number of employees: Entre 250 et 499 salariés (2017)

Capital: 100 685 231


Financial Data:

Year Turnover (€) Net Profit (€) Fiscal Year End Fiscal Year Duration
2019 387 518 103 EUR 6 621 050 EUR 31/12/2019 12
2018 474 574 415 EUR 10 924 390 EUR 31/12/2018 12
2017 362 481 566 EUR 10 968 533 EUR 31/12/2017 12
2016 293 844 924 EUR 7 514 064 EUR 31/12/2016 12
2015 289 222 819 EUR 7 608 056 EUR 31/12/2015 12

Company Managers:

Position First Name Last Name Age Linkedin
Président Philippe Jean Albert EMERY 56
Directeur général Nathalie, Catherine DONZEL 53

Studies mentioning this company

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.